Research ArticleClinical Studies

Radiotherapy of Grade III Gliomas: Identification of Clinical Prognostic Factors for Local Tumor Control and Survival

DIRK RADES, JASPAR WITTELER and STEVEN E. SCHILD
In Vivo November 2020, 34 (6) 3627-3630; DOI: https://doi.org/10.21873/invivo.12208

Article Information

vol. 34 no. 6 3627-3630
DOI 
https://doi.org/10.21873/invivo.12208
PMID 
33144477
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received August 19, 2020
  • Revision received September 6, 2020
  • Accepted September 7, 2020
  • Published online November 3, 2020.
Copyright & License 
Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. DIRK RADES1⇑,
  2. JASPAR WITTELER1 and
  3. STEVEN E. SCHILD2
  1. 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  2. 2Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
  1. Correspondence to: Prof. Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany. Tel: +49 45150045401, Fax: +49 45150045404, e-mail: dirk.rades{at}uksh.de
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Radiotherapy of Grade III Gliomas: Identification of Clinical Prognostic Factors for Local Tumor Control and Survival
DIRK RADES, JASPAR WITTELER, STEVEN E. SCHILD
In Vivo Nov 2020, 34 (6) 3627-3630; DOI: 10.21873/invivo.12208
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords